The debate of dopamine's clinical application

Chinese Critical Care Medicine

Volumn 24, Issue 8, 2012, Pages 451-454

  Tian, Sui Rong ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIURETIC AGENT; DOPAMINE; DOPAMINE RECEPTOR; NEUROTRANSMITTER; NORADRENALIN;

ACUTE KIDNEY FAILURE; CENTRAL VENOUS CATHETER; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG INDUCED DISEASE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; LOW DRUG DOSE; RENAL PROTECTION; SHOCK; SHORT SURVEY; SKIN DISEASE; SKIN ISCHEMIA; TREATMENT PLANNING;

DOPAMINE; HUMANS;

EID: 84866547587     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.08.002     Document Type: Short Survey

References (8)

1. Benes FM. Carlsson and the discovery of dopamine. Trends Pharmacol Sci, 2001,22:46-47.
2. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet, 2000,356:2139-2143.
3. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med, 2001,29:1526-1531.
4. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely ill patients (SOAP) study. Crit Care Med, 2006,34:589-597.
5. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 2010,362:779-789.
6. De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock:a meta-analysis. Crit Care Med,2012,40:725-730.
7. Bracco D. Pharmacologic support of the failing circulation: practice, education, evidence, and future directions. Crit Care Med, 2006,34:890-892.